GSK1349572 (Dolutegravir) is a potent metal-chelating HIV-1 integrase inhibitor. It affects HIV-1 integration and inflammatory signaling pathways, by binding to the catalytic domain and chelating metal ions, to inhibit viral DNA strand transfer and HIV-1 replication.
GSK1349572 (Dolutegravir) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for GSK1349572 (Dolutegravir) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- GSK1349572 (Dolutegravir) Mechanism of Action: HIV-1 Integrase Inhibition in CD4+ T Cell Research
- GSK1349572 (Dolutegravir) Clinical Trials
- GSK1349572 (Dolutegravir): Selectivity & Specificity
- GSK1349572 (Dolutegravir) Working Concentration | Cell Culture | Treatment
- GSK1349572 (Dolutegravir) Solubility in DMSO
- GSK1349572 (Dolutegravir) Stock Solution
- GSK1349572 (Dolutegravir) Storage
- GSK1349572 (Dolutegravir) Stability
- GSK1349572 (Dolutegravir) Combination Database
- GSK1349572 (Dolutegravir) Molecular Weight
- GSK1349572 (Dolutegravir) SMILES
- GSK1349572 (Dolutegravir) CAS Number
- GSK1349572 (Dolutegravir) Chemical Structure (2D and 3D)
- GSK1349572 (Dolutegravir) Sigma (SBR00080)? Try a better option.
- GSK1349572 (Dolutegravir) MedChemExpress (HY-13238)? Try a better option.
- GSK1349572 (Dolutegravir) Cayman (22191)? Try a better option.
- GSK1349572 (Dolutegravir) APExBIO (A4074)? Try a better option.
- GSK1349572 (Dolutegravir) SDS｜MSDS